T. Mulligan

发表

Metabolic Profiles of Minimally Absorbed Orlistat in Obese/Overweight Volunteers

J. Zhi, C. Funk, B. Lausecker, 1996, Journal of clinical pharmacology.

Pharmacokinetic Evaluation of the Possible Interaction between Selected Concomitant Medications and Orlistat at Steady State in Healthy Subjects

J. Zhi, Rema Moore, L. Kanitra, 2002, Journal of clinical pharmacology.

The Effect of Orlistat on the Pharmacokinetics of Phenytoin in Healthy Volunteers

J. Zhi, A. Melia, T. Mulligan, 1996, Journal of clinical pharmacology.

Lack of Effect of Orlistat on the Bioavailability of a Single Dose of Nifedipine Extended‐Release Tablets (Procardia XL) in Healthy Volunteers

J. Zhi, A. Melia, T. Mulligan, 1996, Journal of clinical pharmacology.

Pharmacokinetic Evaluation of the Possible Interaction between Selected Concomitant Medications and Orlistat at Steady State in Healthy Subjects

J. Zhi, Rema Moore, L. Kanitra, 2002, Journal of clinical pharmacology.

Influence of the antacid Maalox on the pharmacokinetics of capecitabine in cancer patients

B. Reigner, D. Jodrell, J. Cassidy, 1999, Cancer Chemotherapy and Pharmacology.

Long‐Term Systemic Exposure of Orlistat, a Lipase Inhibitor, and Its Metabolites in Obese Patients

J. Zhi, J. Hauptman, T. Mulligan, 1999, Journal of clinical pharmacology.

The Analysis of Ro 24–4736 in Human Plasma by Multidimensional Reversed Phase Microbore HPLC/UV

R. Blain, N. Oldfield, B. Mico, 1994 .

Comparison of two barley yellow-dwarf viruses in glasshouse and field experiments.

M. Watson, T. Mulligan, T. E. Mulligan, 1960 .

THE MANNER OF TRANSMISSION OF SOME BARLEY YELLOW‐DWARF VIRUSES BY DIFFERENT APHID SPECIES

M. Watson, T. Mulligan, T. E. Mulligan, 1960 .

The transmission by mites, host-range and properties of ryegrass mosaic virus.

T. Mulligan, T. E. Mulligan, 1960 .

Cereal yellow dwarf virus in Great Britain.

M. Watson, T. Mulligan, T. E. Mulligan, 1957 .